Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-05-02 | OptimizeRx Corp | Silvestro Stephen L
(Chief Commercial Officer) |
M | Common Stock | A | 90000 | $0.00 - $0.00 | $0 |
| 2024-05-02 | OptimizeRx Corp | Silvestro Stephen L
(Chief Commercial Officer) |
F | Common Stock | D | 35415 | $10.70 - $10.70 | $378,940 |
| 2024-03-01 | OptimizeRx Corp | Silvestro Stephen L
(Chief Commercial Officer) |
M | Common Stock | A | 1927 | $0.00 - $0.00 | $0 |
| 2024-03-01 | OptimizeRx Corp | Silvestro Stephen L
(Chief Commercial Officer) |
F | Common Stock | D | 572 | $15.95 - $15.95 | $9,123 |
| 2024-02-15 | OptimizeRx Corp | Silvestro Stephen L
(Chief Commercial Officer) |
A | Common Stock | A | 7750 | $0.00 - $0.00 | $0 |
| 2024-02-15 | OptimizeRx Corp | FEBBO WILLIAM J
(CEO) |
A | Common Stock | A | 15000 | $0.00 - $0.00 | $0 |
| 2024-02-15 | OptimizeRx Corp | Besch Doug
(Chief Product Officer) |
A | Common Stock | A | 4000 | $0.00 - $0.00 | $0 |
| 2024-02-15 | OptimizeRx Corp | Odence-Ford Marion
(General Counsel and CCO) |
A | Common Stock | A | 4267 | $0.00 - $0.00 | $0 |
| 2024-02-15 | OptimizeRx Corp | Stelmakh Edward
(CFO/COO) |
A | Common Stock | A | 7083 | $0.00 - $0.00 | $0 |
| 2024-03-15 | OptimizeRx Corp | Silvestro Stephen L
(Chief Commercial Officer) |
A | Common Stock | A | 7750 | $0.00 - $0.00 | $0 |
| 2023-10-11 | OptimizeRx Corp | Stelmakh Edward
(CFO/COO) |
M | Common | A | 8221 | $0.00 - $0.00 | $0 |
| 2022-10-11 | OptimizeRx Corp | Stelmakh Edward
(CFO/COO) |
F | Common Stock | D | 3539 | $15.17 - $15.17 | $53,686 |
| 2024-04-15 | OptimizeRx Corp | FEBBO WILLIAM J
(CEO) |
A | Common Stock | A | 60000 | $0.00 - $0.00 | $0 |
| 2024-03-01 | OptimizeRx Corp | Odence-Ford Marion
(General Counsel and CCO) |
M | Common Stock | A | 771 | $0.00 - $0.00 | $0 |
| 2024-03-01 | OptimizeRx Corp | Odence-Ford Marion
(General Counsel and CCO) |
F | Common Stock | D | 268 | $15.95 - $15.95 | $4,274 |
| 2024-02-11 | OptimizeRx Corp | Odence-Ford Marion
(General Counsel and CCO) |
M | Common Stock | A | 4000 | $0.00 - $0.00 | $0 |
| 2024-02-11 | OptimizeRx Corp | Odence-Ford Marion
(General Counsel and CCO) |
F | Common Stock | D | 1386 | $15.39 - $15.39 | $21,330 |
| 2024-01-09 | OptimizeRx Corp | FEBBO WILLIAM J
(CEO) |
M | Common Stock | A | 9628 | $0.00 - $0.00 | $0 |
| 2024-01-09 | OptimizeRx Corp | FEBBO WILLIAM J
(CEO) |
F | Common Stock | D | 2884 | $13.25 - $13.25 | $38,213 |
| 2024-01-09 | OptimizeRx Corp | Odence-Ford Marion
(General Counsel and CCO) |
S | Common Stock | D | 4000 | $15.19 - $15.19 | $60,750 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |